Results 11 to 20 of about 6,099,308 (408)

The gut–liver axis and gut microbiota in health and liver disease

Nature Reviews Microbiology, 2023
Cynthia L. Hsu, B. Schnabl
semanticscholar   +3 more sources

A multisociety Delphi consensus statement on new fatty liver disease nomenclature

Hepatology, 2023
The principal limitations of the terms NAFLD and NASH are the reliance on exclusionary confounder terms and the use of potentially stigmatising language.
M. Rinella, J. Lazarus, V. Ratziu, S. Francque, A. Sanyal, F. Kanwal, D. Romero, M. Abdelmalek, Q. Anstee, J. Arab, M. Arrese, R. Bataller, U. Beuers, J. Boursier, E. Bugianesi, C. Byrne, G. C. Castro Narro, A. Chowdhury, H. Cortez‐Pinto, D. Cryer, K. Cusi, Mohamed El-Kassas, S. Klein, Wayne Eskridge, Jian-Gao Fan, S. Gawrieh, C. Guy, S. Harrison, Seung-Up Kim, B. Koot, Marko Korenjak, K. Kowdley, F. Lacaille, R. Loomba, R. Mitchell-Thain, T. Morgan, Elisabeth Powell, M. Roden, M. Romero‐Gomez, Marcelo Silva, S. Singh, S. Sookoian, C. W. Spearman, D. Tiniakos, Luca Valenti, M. Vos, V. Wong, S. Xanthakos, Y. Yılmaz, Z. Younossi, Ansley Hobbs, Marcela Villota-Rivas, P. Newsome   +52 more
semanticscholar   +1 more source

Liver [PDF]

Modern Pathology, 2016
The median waiting time for patients with MELD ≥ 35 decreased from 18 days in 2012 to 9 days in 2014, after implementation of the Share 35 policy in June 2013. Similarly, mortality among candidates listed with MELD ≥ 35 decreased from 366 per 100 waitlist years in 2012 to 315 in 2014.
W R, Kim, J R, Lake, J M, Smith, M A, Skeans, D P, Schladt, E B, Edwards, A M, Harper, J L, Wainright, J J, Snyder, A K, Israni, B L, Kasiske   +10 more
  +9 more sources

Liver transplantation [PDF]

Current Opinion in Gastroenterology, 1998
Continued discussion over organ allocation and distribution remained a focal point in the field of liver transplantation in the year 2000. Despite the ongoing debate, no significant changes were implemented in the current allocation system. By far, the most widely discussed topic in liver transplantation this year was live donor adult-to-adult liver ...
Brown, KA, Moonka, DK
openaire   +6 more sources

Guidelines for the Diagnosis and Treatment of Primary Liver Cancer (2022 Edition)

Liver Cancer, 2023
Background: Primary liver cancer, of which around 75–85% is hepatocellular carcinoma in China, is the fourth most common malignancy and the second leading cause of tumor-related death, thereby posing a significant threat to the life and health of the ...
Jian Zhou, Huichuan Sun, Zheng Wang, Wen-Ling Cong, M. Zeng, Weiping Zhou, P. Bie, Lianxin Liu, Tianfu Wen, M. Kuang, G. Han, Zhiping Yan, Maoqiang Wang, Ruibao Liu, Ligong Lu, Z. Ren, Z. Zeng, P. Liang, C. Liang, Min Chen, Fu-hua Yan, Wenping Wang, Jin-Xiu Hou, Yuan Ji, Jingping Yun, Xueli Bai, Dingfang Cai, Weixia Chen, Yongjun Chen, W. Cheng, Shuqun Cheng, C. Dai, Wenzhi Guo, Ya-bing Guo, B. Hua, Xiaowu Huang, W. Jia, Qiu Li, Tao Li, Xun Li, Yaming Li, Yexiong Li, Jun Liang, Changquan Ling, Tianshu Liu, Xiufeng Liu, Shi-yong Lu, Guoyue Lv, Y. Mao, Z. Meng, Tao Peng, W. Ren, Hongcheng Shi, Guoming Shi, Ming Shi, T. Song, K. Tao, Jianhua Wang, Kui Wang, Lu Wang, Wentao Wang, Xiaoying Wang, Zhiming Wang, Bangde Xiang, B. Xing, Jianming Xu, Jiamei Yang, Jianyong Yang, Yefa Yang, Yun Yang, Shenglong Ye, Zhenyu Yin, Yong Zeng, Bixiang Zhang, Boheng Zhang, Leida Zhang, Shuijun Zhang, Ti Zhang, Yanqiao Zhang, Ming-Hui Zhao, Yongfu Zhao, Honggang Zheng, Ledu Zhou, Jiye Zhu, Kangshun Zhu, Rong Liu, Yinghong Shi, Yongsheng Xiao, Lan Zhang, Chun Yang, Zhi-feng Wu, Z. Dai, Minshan Chen, Jianqiang Cai, Weilin Wang, Xiujun Cai, Qiang Li, Feng Shen, S. Qin, G. Teng, Jiahong Dong, Jiali Fan   +101 more
semanticscholar   +1 more source

Assessing Non-Invasive Liver Function in Patients With Intestinal Failure Receiving Total Parenteral Nutrition-Results From the Prospective PNLiver Trial [PDF]

, 2020
Liver abnormalities in intestinal failure (IF) patients receiving parenteral nutrition (PN) can progress undetected by standard laboratory tests to intestinal failure associated liver disease (IFALD). The aim of this longitudinal study is to evaluate the
Bednarsch, Jan, Blüthner, Elisabeth, Gerlach-Runge, Undine, Karber, Mirjam, Maasberg, Sebastian, Pape, Ulrich-Frank, Pascher, Andreas, Pevny, Sophie, Pratschke, Johann, Stockmann, Martin, Tacke, Frank   +10 more
core   +1 more source

Genome-wide and Mendelian randomisation studies of liver MRI yield insights into the pathogenesis of steatohepatitis [PDF]

, 2020
Background A non-invasive method to grade the severity of steatohepatitis and liver fibrosis is magnetic resonance imaging (MRI) based corrected T1 (cT1).
Banerjee, R, Banerjee, R, Bell, J.D., Bell, J.D., Hemingway, H., Hemingway, H., Hingorani, A.D., Hingorani, A.D., Kelly, M., Kelly, M., McGonigle, J., McGonigle, J., Neubauer, S., Neubauer, S., Nicholls, R.C., Nicholls, R.C., Parisinos, C.A., Parisinos, C.A., Patel, R.S., Patel, R.S., Thomas, E.L., Thomas, E.L., Wilman, H., Wilman, H., Yaghootkar, H., Yaghootkar, H.   +25 more
core   +3 more sources

MAFLD: A consensus-driven proposed nomenclature for metabolic associated fatty liver disease.

Gastroenterology, 2020
Fatty liver associated with metabolic dysfunction is common, affects a quarter of the population, and has no approved drug therapy. While pharmacotherapies are in development, response rates appear modest.
M. Eslam, A. Sanyal, J. George
semanticscholar   +1 more source

NCSTN promotes hepatocellular carcinoma cell growth and metastasis via β-catenin activation in a Notch1/AKT dependent manner

Journal of Experimental & Clinical Cancer Research, 2020
Background Hepatocellular carcinoma is the third top cause of cancer-related mortalities worldwide. The prognosis of HCC patients remains poor due to rapid progression and high incidence of tumor recurrence.
Hui Li, Tian Lan, Lin Xu, Hailing Liu, Jinju Wang, Jiaxin Li, Xiangzheng Chen, Jiwei Huang, Xuefeng Li, Kefei Yuan, Yong Zeng, Hong Wu   +11 more
doaj   +1 more source

Loss of 5-hydroxymethylcytosine induces chemotherapy resistance in hepatocellular carcinoma via the 5-hmC/PCAF/AKT axis

Cell Death and Disease, 2023
Multidrug resistance is a major challenge in treating advanced hepatocellular carcinoma (HCC). Although recent studies have reported that the multidrug resistance phenotype is associated with abnormal DNA methylation in cancer cells, the epigenetic ...
Xiao-Jun Guo, Xiao-Yong Huang, Xuan Yang, Jia-Cheng Lu, Chuan-Yuan Wei, Chao Gao, Yan-Zi Pei, Yi Chen, Qi-Man Sun, Jia-Bin Cai, Jian Zhou, Jia Fan, Ai-Wu Ke, Yujiang G. Shi, Ying-Hao Shen, Peng-Fei Zhang, Guo-Ming Shi, Guo-Huan Yang   +17 more
doaj   +1 more source